These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8883580)

  • 21. env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area.
    Corbet S; Müller-Trutwin MC; Versmisse P; Delarue S; Ayouba A; Lewis J; Brunak S; Martin P; Brun-Vezinet F; Simon F; Barre-Sinoussi F; Mauclere P
    J Virol; 2000 Jan; 74(1):529-34. PubMed ID: 10590144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
    Jenkins M; Mills J; Kohl S
    Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz.
    Keele BF; Jones JH; Terio KA; Estes JD; Rudicell RS; Wilson ML; Li Y; Learn GH; Beasley TM; Schumacher-Stankey J; Wroblewski E; Mosser A; Raphael J; Kamenya S; Lonsdorf EV; Travis DA; Mlengeya T; Kinsel MJ; Else JG; Silvestri G; Goodall J; Sharp PM; Shaw GM; Pusey AE; Hahn BH
    Nature; 2009 Jul; 460(7254):515-9. PubMed ID: 19626114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
    Jewett A; Giorgi JV; Bonavida B
    J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on V3-specific cross-reactive T-cell responses in chimpanzees chronically infected with HIV-1IIIB.
    Nehete PN; Murthy KK; Satterfield WC; Arlinghaus RB; Sastry KJ
    AIDS; 1995 Jun; 9(6):567-72. PubMed ID: 7662194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
    Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
    J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).
    Jewett A; Bonavida B
    Clin Immunol Immunopathol; 1990 Feb; 54(2):192-9. PubMed ID: 2104787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.
    Shibata R; Siemon C; Cho MW; Arthur LO; Nigida SM; Matthews T; Sawyer LA; Schultz A; Murthy KK; Israel Z; Javadian A; Frost P; Kennedy RC; Lane HC; Martin MA
    J Virol; 1996 Jul; 70(7):4361-9. PubMed ID: 8676459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee.
    Santiago ML; Bibollet-Ruche F; Bailes E; Kamenya S; Muller MN; Lukasik M; Pusey AE; Collins DA; Wrangham RW; Goodall J; Shaw GM; Sharp PM; Hahn BH
    J Virol; 2003 Feb; 77(3):2233-42. PubMed ID: 12525658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees.
    Gibbs CJ; Peters R; Gravell M; Johnson BK; Jensen FC; Carlo DJ; Salk J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3348-52. PubMed ID: 2014254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.
    Robinson WE; Montefiori DC; Mitchell WM; Prince AM; Alter HJ; Dreesman GR; Eichberg JW
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4710-4. PubMed ID: 2471977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.
    Sato K; Misawa N; Takeuchi JS; Kobayashi T; Izumi T; Aso H; Nagaoka S; Yamamoto K; Kimura I; Konno Y; Nakano Y; Koyanagi Y
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination.
    ten Haaft P; Cornelissen M; Goudsmit J; Koornstra W; Dubbes R; Niphuis H; Peeters M; Thiriart C; Bruck C; Heeney JL
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():1015-20. PubMed ID: 9049351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of simian immunodeficiency virus infection in a community of savanna chimpanzees.
    Rudicell RS; Piel AK; Stewart F; Moore DL; Learn GH; Li Y; Takehisa J; Pintea L; Shaw GM; Moore J; Sharp PM; Hahn BH
    J Virol; 2011 Oct; 85(19):9918-28. PubMed ID: 21775446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.
    Bruel T; Guivel-Benhassine F; Lorin V; Lortat-Jacob H; Baleux F; Bourdic K; Noël N; Lambotte O; Mouquet H; Schwartz O
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrasting effects of natural selection on human and chimpanzee CC chemokine receptor 5.
    Wooding S; Stone AC; Dunn DM; Mummidi S; Jorde LB; Weiss RK; Ahuja S; Bamshad MJ
    Am J Hum Genet; 2005 Feb; 76(2):291-301. PubMed ID: 15625621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions.
    Peeters M; Nkengasong J; Willems B; Karita E; Delaporte E; Van den Haesevelde M; Piot P; van der Groen G
    AIDS; 1994 Dec; 8(12):1657-61. PubMed ID: 7888113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine.
    Cox JH; Garner RP; Redfield RR; Aronson NE; Davis C; Ruiz N; Birx DL
    AIDS Res Hum Retroviruses; 1999 Jun; 15(9):847-54. PubMed ID: 10381173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.